Memeber of the Board of Directors at Machavert Pharmaceuticals - , Colorado, United States
CEO & Founder
Contact Jakub Staszak
Contact Jakub Staszak-Jirkovsky
Executive Assistant
Contact Beata Staszak-Jirkovska
Senior Analytical Chemist
Contact Chris Johnson
Machavert develops first in class small molecule RAL GTPase inhibitors that target KRAS mutant cancers growth and metastasis.